What is AptarGroup, Inc. (ATR) stock price today?

AptarGroup, Inc. (ATR) is currently trading at $121.81, up 1.15% today.

What is ATR P/E ratio?

AptarGroup, Inc.'s P/E ratio is 21.41. This is near the market average.

What is ATR return on equity (ROE)?

AptarGroup, Inc.'s return on equity (ROE) is 13.52%, indicating how efficiently the company generates profit from shareholders' equity. This is above the market average.

What is AptarGroup, Inc.'s market cap?

AptarGroup, Inc. has a market capitalization of $7.77B.

NYSE · Medical - Instruments & Supplies

AptarGroup, Inc. (ATR) Stock

$121.81 +1.15% NYSE: ATR Healthcare

Valuation

Metric	Value
Price	$121.81
Market Cap	$7.77B
P/E Ratio	21.41
P/B Ratio	2.91
P/S Ratio	1.95
EPS (TTM)	$5.88
52-Week High	$146.91
52-Week Low	$103.23
Dividend Yield	1.60%

Financials & Margins

Metric	Value
ROE	13.52%
ROA	7.06%
ROCE	12.17%
Gross Margin	13.56%
Operating Margin	13.56%
Net Margin	9.22%
Debt/Equity	0.54
Current Ratio	1.62

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$3.2B	$3.3B	$3.5B	$3.6B	$3.8B
Operating Profit	$347.0M	$379.0M	$404.0M	$496.0M	$512.0M
Net Profit	$244.0M	$239.0M	$284.0M	$375.0M	$393.0M
EPS	$3.60	$3.59	$4.25	$5.53	$5.88
Op Margin	10.8%	11.4%	11.6%	13.9%	13.6%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$4.1B	$4.2B	$4.5B	$4.4B	$5.3B
Total Liabilities	$2.2B	$2.1B	$2.1B	$1.9B	$2.5B
Cash	$123.0M	$142.0M	$224.0M	$224.0M	$402.0M
Borrowings	$1.2B	$1.2B	$1.2B	$1.1B	$1.5B

Latest News

ATR: Raising target price to $135.00 Argus Research · Jul 15, 2026 Packaging, Forest Products Face Lackluster Demand, Weak Volumes, BofA Says MT Newswires · Jul 14, 2026 BofA Upgrades AptarGroup to Buy From Neutral, Price Target is $173 MT Newswires · Jul 14, 2026 Aptar Named Among Top 100 of America’s Best Companies by TIME Business Wire · Jul 13, 2026 Aptar Releases 2025 Corporate Sustainability Report Business Wire · Jun 18, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$363.0M	$479.0M	$575.0M	$643.0M	$570.0M
Investing Cash Flow	$-765.0M	$-611.0M	$-643.0M	$-691.0M	$-601.0M
Financing Cash Flow	$-20.0M	$-68.0M	$-16.0M	$-14.0M	$-365.0M
Net Cash Flow	$-182.0M	$20.0M	$81.0M	$0	$178.0M
Free Cash Flow	$56.0M	$163.0M	$257.0M	$349.0M	$300.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-4.08
EV / EBITDA	10.81
FCF Yield	4.06%
Quick Ratio	1.10
Interest Coverage	7.66
Return 1Y	-7.44%
Return 3Y	-1.10%
Return 5Y	3.35%

Ownership

Insiders Held0.88%

Institutions Held97.12%

Institutions Float Held97.98%

Institutional Holder	Shares	Report Date
Blackrock Inc.	6,083,518	2026-03-31
State Farm Mutual Automobile Insurance Co	4,744,564	2026-03-31
Vanguard Portfolio Management LLC	3,767,772	2026-03-31
Morgan Stanley	3,375,796	2026-03-31
Vanguard Capital Management LLC	2,885,297	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$340.42	+1.11%	38.93	$5.00T	0.32%
MSFTMicrosoft Corporation	$522.61	-1.35%	28.68	$3.88T	0.76%
GOOGLAlphabet Inc.	$348.29	-0.63%	16.94	$4.22T	0.26%
AMZNAmazon.com, Inc.	$254.06	-2.25%	19.82	$2.73T	0.00%
METAMeta Platforms, Inc.	$720.89	-0.06%	27.93	$1.84T	0.28%

About AptarGroup, Inc.

AptarGroup, Inc. is led by CEO Stephan Tanda, employs 14,000 people, headquartered in Crystal Lake, US, publicly traded since 1993.

AptarGroup, Inc. (ATR) stock trades at $121.81 with a market capitalization of $7.77B. The stock is valued at a price-to-earnings (P/E) ratio of 21.41, price-to-book of 2.91, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $103.23 and $146.91, and currently trades 17.1% below its 52-week high. It pays a dividend yielding 1.60%.

On profitability, AptarGroup, Inc. generates a return on equity (ROE) of 13.52%, above the typical market average, return on capital employed of 12.17%, an operating margin of 13.56%, a net profit margin of 9.22%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides